Assessment of coagulation disorders and cancer procoagulant activity in patients with myelodysplastic syndromes

Neoplasma

Volumn 49, Issue 3, 2002, Pages 155-158

  Chojnowski, K ^a   Trelinski J ^a   Wawrzyniak, E ^a   Sobolewska, M ^a   Mielicki, W P ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cancer procoagulant; Coagulation activation markers; Myelodysplastic syndromes

Indexed keywords

D DIMER; PROCOAGULANT; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ACUTE LEUKEMIA; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; MYELODYSPLASTIC SYNDROME; THROMBOCYTOPENIA;

EID: 0036304918     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Elevated serum TNF-alpha concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes
2. Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrow of patients with myelodysplastic syndromes
3. Pulmonary thromboembolism associated with myelodysplastic syndrome
4. Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: A report on six cases
5. Assessement of coagulation disorders in patients with acute leukemia before and after cytostatic treatment
6. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia
7. Cancer procoagulant in acute non lymphoid leukemia: Relationship of enzyme detection to disease activity
8. Procoagulant cell activities in acute leukemia
9. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid
10. Hemostasis and malignancy
11. Analysis of serum cancer procoagulant activity and its possible use as a tumor marker
12. Myelodysplasia
13. Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant
14. Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients
15. Platelet function in the myelodysplastic syndromes
16. Early detection of relapse in acute non-lymphoblastic leukemia patients by cancer procoagulant assay
17. A continuous spectrum of hypercoagul-ability exists in acute nonlymphoblastic leukemia
18. New isights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia